2015
DOI: 10.15171/ijb.1096
|View full text |Cite
|
Sign up to set email alerts
|

Association of Two Polymorphic Codons in P53 and ABCC1 Promoter with Prostate Cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(6 citation statements)
references
References 34 publications
0
6
0
Order By: Relevance
“…Cortez et al suggested that p53 mutants could intervene in the immune escape of tumors by regulating the expression of PD-L1 [ 24 ]. Moreover, p53 has been verified to mutate in prostate cancer [ 25 ]. Wig1, a transcriptional target of p53, encodes an unusual zinc finger protein that participates in post-transcriptional gene regulation.…”
Section: Discussionmentioning
confidence: 99%
“…Cortez et al suggested that p53 mutants could intervene in the immune escape of tumors by regulating the expression of PD-L1 [ 24 ]. Moreover, p53 has been verified to mutate in prostate cancer [ 25 ]. Wig1, a transcriptional target of p53, encodes an unusual zinc finger protein that participates in post-transcriptional gene regulation.…”
Section: Discussionmentioning
confidence: 99%
“…It has even recently been found to be used in chest high-resolution computed tomography imaging findings of coronavirus disease 2019 (Covid-19) pneumonia (42). Cancer research has yielded good results through the study of gene expression as well as biotechnological methods (43)(44)(45)(46)(47)(48).…”
Section: Discussionmentioning
confidence: 99%
“…The p53Arg72 protein persuades apoptosis faster and represses alteration more competently than the p53Pro72 protein ( 27 ). There have been reports showing possible involvement of P53c72 polymorphism in individuals’ susceptibility to cancers including mouth cancer, breast cancer, thyroid cancer, colorectal, and prostate cancer, which seem to have a mutation in this gene ( 9 , 11 , 13 , 14 , 24 ). The mentioned case-control studies showed the contribution of P53c72 polymorphism to the carcinogenesis although these studies were done with a small sample size and the results from these individual studies lacked consensus.…”
Section: Discussionmentioning
confidence: 99%